|
🦁
|
In Vitro Susceptibilities of Wild-Type or Drug-Resistant Hepatitis B Virus to (−)-β-d-2,6-Diaminopurine Dioxolane and 2′-Fluoro-5-Methyl-β-l-Arabinofuranosyluracil
10 auth.
R. Chin,
T. Shaw,
J. Torresi,
V. Sozzi,
C. Trautwein,
T. Bock,
...
M. Manns,
H. Isom,
P. Furman,
S. Locarnini
|
6 |
2001 |
6
🦁
|
|
🐜
|
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus
29 auth.
G. Ebert,
G. Ebert,
Simon P. Preston,
Simon P. Preston,
C. Allison,
C. Allison,
James P. Cooney,
J. Toe,
J. Toe,
M. Stutz,
M. Stutz,
S. Ojaimi,
S. Ojaimi,
Hamish W Scott,
N. Baschuk,
...
U. Nachbur,
U. Nachbur,
J. Torresi,
R. Chin,
D. Colledge,
Xin Li,
N. Warner,
P. Revill,
S. Bowden,
J. Silke,
J. Silke,
C. Begley,
M. Pellegrini,
M. Pellegrini
|
6 |
2015 |
6
🐜
|
|
🦁
|
Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis.
9 auth.
R. Chin,
L. Earnest-Silveira,
B. Koeberlein,
Susanne Franz,
H. Zentgraf,
Xuebin Dong,
...
E. Gowans,
C. Bock,
J. Torresi
|
6 |
2007 |
6
🦁
|
|
🐜
|
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals.
20 auth.
Eric J. Gowans,
S. Roberts,
K. Jones,
I. Dinatale,
P. Latour,
B. Chua,
Emily M. Eriksson,
R. Chin,
Shuo Li,
Dominic Wall,
...
Rosemary L. Sparrow,
Jude Moloney,
M. Loudovaris,
R. Ffrench,
H. M. Prince,
D. Hart,
W. Zeng,
J. Torresi,
Lorena E. Brown,
David C. Jackson
|
6 |
2010 |
6
🐜
|
|
🐜
|
ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.
9 auth.
K. Mak,
R. Chin,
S. Cunningham,
M. Habib,
J. Torresi,
Alexandra F. Sharland,
...
I. Alexander,
P. Angus,
C. Herath
|
5 |
2015 |
5
🐜
|
|
🦁
|
In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.
10 auth.
R. Chin,
T. Shaw,
J. Torresi,
V. Sozzi,
C. Trautwein,
T. Bock,
...
M. Manns,
H. Isom,
P. Furman,
S. Locarnini
|
5 |
2001 |
5
🦁
|
|
🐜
|
Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses
8 auth.
B. Chua,
Douglas F. Johnson,
Amabel C. L. Tan,
L. Earnest-Silveira,
Toshiki Sekiya,
R. Chin,
...
J. Torresi,
D. Jackson
|
5 |
2012 |
5
🐜
|
|
🐜
|
Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver.
9 auth.
B. Koeberlein,
A. zur Hausen,
N. Bektas,
H. Zentgraf,
R. Chin,
L. Nguyen,
...
R. Kandolf,
J. Torresi,
C. Bock
|
5 |
2010 |
5
🐜
|
|
🦁
|
Treatment of chronic hepatitis B: current challenges and future directions
R. Chin,
S. Locarnini
|
5 |
2003 |
5
🦁
|
